Copyright
©2011 Baishideng Publishing Group Co.
World J Biol Chem. Jan 26, 2011; 2(1): 14-24
Published online Jan 26, 2011. doi: 10.4331/wjbc.v2.i1.14
Published online Jan 26, 2011. doi: 10.4331/wjbc.v2.i1.14
Inhibitor (% inhibition) | Alternative name | MW (g/mol) | Target | Mechanism | Ref. |
Aprotinin (5%) | Bovine pancreatic trypsin inhibitor | Approximately 6500 | Serine proteases including plasmin, tissue plasminogen activator, kallikrein and thrombin | Nonspecific protease inhibitor | [33,34] |
Batimastat (94%) | BB-94; [4-(N-hydroxyamino)-2R-isobutyl-3S-(thiopen-2-ylthiomethyl)succinyl]-L-phenylalanine-N-methylamide | 478 | MMP-1, -2, -3, -7 and -9 | Peptide backbone similar to the cleavage site in collagen (= peptidomimetic inhibitor) | [6,9,35-37] |
TACE (MMP IC50 = 10-30 nmol/L) | |||||
Benzamidine (0%) | - | 120 | Trypsin, plasmin and thrombin | Competitive inhibitor | [36] |
Bestatin (0%) | [(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine, Ubenimex | 308 | Aminopeptidase N | Slow-binding competitive inhibitor | [38-40] |
Chymostatin (0%) | - | 608 | Proteinases including Serine, thiol, and carboxyl endopeptidases serine proteinases, chymotrypsin and Streptomyces griseus proteinase A, and several cysteine proteinases | Tetrapeptide analogue, formation of a hemiacetal or hemithioacetal adduct with the nucleophilic hydroxy or thiol group of the serine and cysteine proteinases | [41,42] |
E-64d (0%) | Aloxistatin, EST, [2S,3S-trans-(Ethoxycarbonyloxirane-2-carbonyl)-L leucine-(3-methylbutyl) amide] | 342 | Specific thiol protease inhibitor such as papain and cathepsin B | Interaction with active thiol group | [43] |
EGCG (33%) | Epigallocatechin-3-gallate | 458 | Multiple targets including MMP-2 and MMP-9 (MMP IC50 = 8-50 μmol/L) | Blocking the activation mechanism of MMP-2 induced by concanavalin A | [44-47] |
Other exact molecular targets remain unknown | |||||
Pefabloc (0%) | AEBSF; 4-(2-Aminoethyl) benzenesulfonyl fluoride hydrochloride | 239 | Serine protease inhibitor | Irreversible inhibition by covalent interaction with the active-site serine | [48,49] |
Pepstatin (0%) | Isovaleryl-L-valyl-L-valyl-4-amino-3-hydroxy-6-methylheptanoyl-L- alanyl-4-amino-3-hydroxy-6-methylheptanoic acid | 686 | Pepsin and gastricsin (acid proteinase activity) | - | [50] |
PMSF (0%) | Phenylmethylsulfonyl fluoride | 174 | Serine protease/carboxylesterase inhibitor | Covalent binding to the serine residue of the catalytic Ser-His-Asp triad | [51] |
SB-3CT (91%) | - | 306 | MMP-2 and MMP-9 (MMP IC50 = 185-290 nmol/L) | Competitive, mechanism-based, thiirane-opening mechanism | [8,52] |
- Citation: Vandooren J, Geurts N, Martens E, Steen PEVD, Jonghe SD, Herdewijn P, Opdenakker G. Gelatin degradation assay reveals MMP-9 inhibitors and function of O-glycosylated domain. World J Biol Chem 2011; 2(1): 14-24
- URL: https://www.wjgnet.com/1949-8454/full/v2/i1/14.htm
- DOI: https://dx.doi.org/10.4331/wjbc.v2.i1.14